## Abstract ## Purpose To investigate intra‐ and interscanner in vivo reproducibility of brain metabolite quantification using ^1^H magnetic resonance spectroscopic imaging (^1^H‐MRSI) (PRESS localization, TE = 30 msec, voxel volume = 2.3 mL) and the linear combination model (LCModel). ## Materia
Metabolites in ventricular cerebrospinal fluid detected by proton magnetic resonance spectroscopic imaging
✍ Scribed by Lidia M. Nagae-Poetscher; Michael McMahon; Nancy Braverman; William T. Lawrie Jr.; Ali Fatemi; Mahaveer Degaonkar; Alena Horská; Martin G. Pomper; Vaddapuram P. Chacko; Peter B. Barker
- Publisher
- John Wiley and Sons
- Year
- 2004
- Tongue
- English
- Weight
- 358 KB
- Volume
- 20
- Category
- Article
- ISSN
- 1053-1807
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Normally, ventricular cerebrospinal fluid (CSF) contains low levels of all metabolite signals on proton magnetic resonance spectroscopic imaging (MRSI). We present here three cases (two with seizure disorders, one with a central nervous system lymphoma) who presented with unusually elevated CSF signals on MRSI. Based on chemical shifts and in vitro studies (in one case), the signals were assigned to propan‐1,2‐diol (PD), acetone, and lactate, respectively. These compounds were either exclusively, or more readily, detected in CSF than in brain. Proton MRSI conveniently screens both brain and CSF for abnormal metabolism simultaneously. J. Magn. Reson. Imaging 2004;20:496–500. © 2004 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES
## Abstract In the present study we applied proton‐decoupled ^31^P magnetic resonance spectroscopic imaging (MRSI) to noninvasively assess liver metabolism in patients who had undergone a partial hepatectomy (PH). Proton‐decoupled ^31^P chemical shift imaging was performed in 47 patients 2–28 days